SNHG15 and thyroid cancer: Its overexpression is closely associated with clinical malignant phenotypes, suggesting that SNHG15 not only plays a crucial role in the initiation and progression of thyroid cancer but may also serve as a potential therapeutic target and prognostic biomarker.